ADD CONDITION
Water
Last content change checked dailysee data sync status
- Active ingredient
- Water 1 mL/1 mL
- Other brand names
- Bacteriostatic Water (by Henry Schein, Inc.)
- Sterile Water (by B. Braun Medical Inc.)
- Sterile Water (by B. Braun Medical Inc.)
- Sterile Water (by B. Braun Medical Inc.)
- Sterile Water (by B. Braun Medical Inc.)
- Sterile Water (by Baxter Healthcare Company)
- Sterile Water (by Baxter Healthcare Company)
- Sterile Water (by Baxter Healthcare Company)
- Sterile Water (by Baxter Healthcare Corporation)
- Sterile Water (by Becton Dickinson and Company)
- Sterile Water (by Cardinal Health 107, Llc)
- Sterile Water (by Cardinal Health 107, Llc)
- Sterile Water (by Chartwell Rx, Llc)
- Sterile Water (by Civica, Inc.)
- Sterile Water (by Fresenius Kabi Usa, Llc)
- Sterile Water (by Fresenius Kabi Usa, Llc)
- Sterile Water (by Fresenius Kabi Usa, Llc)
- Sterile Water (by Fresenius Kabi Usa, Llc)
- Sterile Water (by General Injectables and Vaccines, Inc.)
- Sterile Water (by Henry Schein, Inc.)
- Sterile Water (by Henry Schein, Inc.)
- Sterile Water (by Henry Schein, Inc.)
- Sterile Water (by Hikma Pharmaceuticals Usa Inc.)
- Sterile Water (by Hikma Pharmaceuticals Usa Inc.)
- Sterile Water (by Hospira, Inc.)
- Sterile Water (by Hospira, Inc.)
- Sterile Water (by Icu Medical Inc.)
- Sterile Water (by Icu Medical Inc.)
- Sterile Water (by Icu Medical Inc.)
- Sterile Water (by Icu Medical Inc.)
- Sterile Water (by Medefil, Inc.)
- Sterile Water (by Nephron Pharmaceuticals Corporation)
- View full label-group details →
- Dosage form
- Injection, Solution
- Routes
- Intramuscular
- Intravenous
- Subcutaneous
- Prescription status
- Rx (prescription)
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
- Marketed in the U.S.
- Since 2005
- Label revision date
- December 5, 2024
- FDA Insert
- Prescribing information, PDF file
- Active ingredient
- Water 1 mL/1 mL
- Other brand names
- Bacteriostatic Water (by Henry Schein, Inc.)
- Sterile Water (by B. Braun Medical Inc.)
- Sterile Water (by B. Braun Medical Inc.)
- Sterile Water (by B. Braun Medical Inc.)
- Sterile Water (by B. Braun Medical Inc.)
- Sterile Water (by Baxter Healthcare Company)
- Sterile Water (by Baxter Healthcare Company)
- Sterile Water (by Baxter Healthcare Company)
- Sterile Water (by Baxter Healthcare Corporation)
- Sterile Water (by Becton Dickinson and Company)
- Sterile Water (by Cardinal Health 107, Llc)
- Sterile Water (by Cardinal Health 107, Llc)
- Sterile Water (by Chartwell Rx, Llc)
- Sterile Water (by Civica, Inc.)
- Sterile Water (by Fresenius Kabi Usa, Llc)
- Sterile Water (by Fresenius Kabi Usa, Llc)
- Sterile Water (by Fresenius Kabi Usa, Llc)
- Sterile Water (by Fresenius Kabi Usa, Llc)
- Sterile Water (by General Injectables and Vaccines, Inc.)
- Sterile Water (by Henry Schein, Inc.)
- Sterile Water (by Henry Schein, Inc.)
- Sterile Water (by Henry Schein, Inc.)
- Sterile Water (by Hikma Pharmaceuticals Usa Inc.)
- Sterile Water (by Hikma Pharmaceuticals Usa Inc.)
- Sterile Water (by Hospira, Inc.)
- Sterile Water (by Hospira, Inc.)
- Sterile Water (by Icu Medical Inc.)
- Sterile Water (by Icu Medical Inc.)
- Sterile Water (by Icu Medical Inc.)
- Sterile Water (by Icu Medical Inc.)
- Sterile Water (by Medefil, Inc.)
- Sterile Water (by Nephron Pharmaceuticals Corporation)
- View full label-group details →
- Dosage form
- Injection, Solution
- Routes
- Intramuscular
- Intravenous
- Subcutaneous
- Prescription status
- Rx (prescription)
- CSA schedule
- Not a scheduled drug
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
- Marketed in the U.S.
- Since 2005
- Label revision date
- December 5, 2024
- Manufacturer
- Hospira, Inc.
- Registration number
- NDA018802
- NDC roots
- 0409-1093, 0409-3977
- FDA Insert
- Prescribing information, PDF file
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
If you are a consumer or patient please visit this version.
Drug Overview
Bacteriostatic Water for Injection, USP is a sterile solution designed specifically for medical use. It contains water that is safe for injection and includes 0.9% benzyl alcohol, which acts as a preservative to prevent bacterial growth. This preparation is supplied in a multiple-dose container, allowing healthcare providers to withdraw the solution multiple times to dilute or dissolve medications before they are injected into the body.
This product is intended solely for parenteral (injection) use, meaning it is used to prepare drugs that need to be mixed with a liquid before administration. It is important to follow the manufacturer's instructions for the specific medication being prepared, as Bacteriostatic Water is not suitable for use in neonates (newborns).
Uses
This medication is specifically designed for diluting or dissolving other drugs that are to be given through injections, whether they are intravenous (into a vein), intramuscular (into a muscle), or subcutaneous (under the skin). It's important to follow the manufacturer's instructions for the drug you are preparing to ensure safe and effective use.
Please note that this preparation is not suitable for use in neonates (newborns), so it should be avoided in that age group. Always consult with a healthcare professional if you have any questions about its use.
Dosage and Administration
When preparing a medication for injection, the amount of liquid you need to use for diluting or dissolving the drug depends on the concentration of the liquid (called the vehicle), the dose you need, and the method of administration recommended by the manufacturer. It's important to follow these guidelines closely to ensure the medication is effective and safe.
Before you administer the medication, take a moment to visually inspect the solution. Look for any particles or discoloration in the liquid and the container. This step is crucial because it helps ensure that the medication is safe to use. If you notice anything unusual, do not use the solution and consult your healthcare provider for further instructions.
What to Avoid
It's important to be aware of certain situations where you should avoid using products containing benzyl alcohol. If you are caring for a newborn, do not use any solutions that contain benzyl alcohol, as it can be toxic to them. Additionally, these preparations should not be used for fluid replacement or in procedures like epidural or spinal anesthesia.
Always prioritize safety by following these guidelines to prevent any potential harm. If you have any questions or concerns about the use of these products, consult with a healthcare professional for guidance.
Side Effects
You may experience some side effects from using this solution, which can include fever, tenderness at the injection site, abscess (a collection of pus), tissue damage or infection, and blood clots or inflammation in the veins near the injection site. In some cases, the solution may leak out of the vein (extravasation), leading to further complications.
It's important to note that if you are a parent or caregiver, solutions containing benzyl alcohol should not be used in newborns due to potential toxicity. Additionally, using Bacteriostatic Water for Injection without a solute can cause the breakdown of red blood cells (hemolysis). Always consult with a healthcare professional regarding the safe use of this product, especially in children and neonates.
Warnings and Precautions
It's important to be aware that Bacteriostatic Water for Injection contains benzyl alcohol, which can be harmful to newborns. If you need to prepare or dilute medications for infants, make sure to use preservative-free Sterile Water for Injection instead, as there is no information on the safety of other preservatives for this age group.
Additionally, if Bacteriostatic Water for Injection is given directly into a vein without mixing it with another substance (solute), it can cause hemolysis, which is the breakdown of red blood cells. If you experience any unusual symptoms or reactions, stop using the product and contact your doctor immediately. Always prioritize safety and consult with a healthcare professional if you have any concerns.
Overdose
If you suspect an overdose, it's important to act quickly. An overdose can happen if the medication is used improperly, such as using it in ways other than as a diluent or solvent. While this preparation is generally safe and unlikely to cause fluid overload, very small infants may be at risk.
Signs of an overdose can include unusual symptoms or reactions. If you notice any concerning changes in your health or the health of someone else, it's crucial to seek immediate medical help. Always re-evaluate the situation and take appropriate corrective measures if an overdose is suspected. Your safety is the top priority, so don’t hesitate to contact a healthcare professional for guidance.
Pregnancy Use
There have been no animal studies conducted to assess the effects of Bacteriostatic Water for Injection during pregnancy. Additionally, it is unclear whether this product, especially when it contains additives, could harm a developing fetus or affect your ability to conceive. Therefore, if you are pregnant, Bacteriostatic Water for Injection should only be used if it is clearly necessary and recommended by your healthcare provider. Always discuss any concerns or questions with your doctor to ensure the best care for you and your baby.
Lactation Use
When breastfeeding, it's important to be cautious about the medications you use, especially if they contain benzyl alcohol. This substance can be toxic to newborns, so you should avoid any solutions with benzyl alcohol while nursing. If you need to prepare or dilute medications for your baby, make sure to use only preservative-free Sterile Water for Injection. This ensures that you are minimizing any potential risks to your infant's health. Always consult with your healthcare provider if you have questions about medications and breastfeeding.
Pediatric Use
When considering Bacteriostatic Water for Injection for your child, it's important to note that its safety and effectiveness have not been established for pediatric patients (children). This means that there isn't enough research to confirm that it is safe or works well for kids.
Additionally, if your child is a newborn (neonate), you should avoid using any solutions that contain benzyl alcohol, as they can be harmful. Always consult with your child's healthcare provider for the best options and guidance regarding medications and treatments.
Geriatric Use
When it comes to using this medication in older adults, there is no specific information available about how it should be adjusted for dosage or any unique safety concerns. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider for personalized advice. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.
Renal Impairment
If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations related to renal impairment (kidney issues) are not provided.
Always consult your healthcare provider for personalized advice and to ensure that any medications you take are safe and appropriate for your kidney health. They can help you understand how your condition may affect your treatment plan.
Hepatic Impairment
If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, but you should always consult your healthcare provider for personalized advice. They can help determine the best approach for your treatment and monitor your liver function as needed.
Make sure to keep your doctor informed about your liver health, as they may want to conduct regular tests to ensure your safety while using any medication. Your well-being is a priority, so don't hesitate to ask questions or express any concerns you may have.
Drug Interactions
It's important to be aware that some injectable medications may not mix well with certain solutions or with each other, especially if they contain benzyl alcohol. This can lead to complications or reduced effectiveness of the medications. To ensure your safety and the best possible outcomes, always discuss any medications you are taking with your healthcare provider or pharmacist. They can help you understand potential interactions and make informed decisions about your treatment.
Storage and Handling
To ensure the best performance and safety of your product, store it at a temperature between 20 to 25°C (68 to 77°F). This range is considered a controlled room temperature, which helps maintain the integrity of the device.
When handling the product, make sure to do so in a clean environment to avoid contamination. Always follow any specific instructions provided for use and disposal to ensure safety and effectiveness.
Additional Information
You can receive this medication through different methods, including intravenous (IV), intramuscular (IM), or subcutaneous (under the skin) injections. It's important to follow the manufacturer's instructions carefully when preparing the medication. This includes choosing the right vehicle (the liquid used to dissolve the drug), the appropriate dilution, and the correct volume for injection, as well as understanding the route and rate at which the drug should be administered. Always consult these instructions to ensure safe and effective use.
FAQ
What is Bacteriostatic Water for Injection, USP?
Bacteriostatic Water for Injection, USP is a sterile, nonpyrogenic preparation of water for injection that contains 0.9% or 1.1% benzyl alcohol as a preservative.
What is the primary use of Bacteriostatic Water for Injection?
It is indicated for diluting or dissolving drugs for intravenous, intramuscular, or subcutaneous injection, according to the manufacturer's instructions.
Is Bacteriostatic Water for Injection safe for neonates?
No, it must not be used in neonates due to the potential toxicity of benzyl alcohol.
What precautions should be taken when using Bacteriostatic Water for Injection?
Inspect parenteral drug products for particulate matter and discoloration before administration, and consult a pharmacist for drug compatibility.
What are the potential adverse reactions associated with Bacteriostatic Water for Injection?
Possible reactions include febrile response, local tenderness, abscess, tissue necrosis, and venous thrombosis or phlebitis.
What should be done if Bacteriostatic Water for Injection is administered without a solute?
Intravenous administration without a solute may result in hemolysis, which is the destruction of red blood cells.
What are the storage conditions for Bacteriostatic Water for Injection?
Store it at 20 to 25°C (68 to 77°F) as per USP Controlled Room Temperature guidelines.
Can Bacteriostatic Water for Injection be used during pregnancy?
Animal reproduction studies have not been conducted, and it should only be used in pregnant women if clearly needed.
Packaging Info
The table below lists all NDC Code configurations of Bacteriostatic Water, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Details | ||||
|---|---|---|---|---|
| Injection, Solution | 1 mL/1 mL | ||
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Injection, Solution | 1 mL/1 mL | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
FDA Insert (PDF)
This is the full prescribing document for Bacteriostatic Water, submitted to the U.S. Food and Drug Administration (FDA). It contains official information for healthcare providers, including how to use the medication, possible side effects, and safety warnings.
Description
This preparation is intended exclusively for parenteral use following the addition of drugs that necessitate dilution or must be dissolved in an aqueous vehicle prior to injection. Bacteriostatic Water for Injection, USP is a sterile, nonpyrogenic solution containing 0.9% (9 mg/mL) or 1.1% (11 mg/mL) of benzyl alcohol, which serves as a bacteriostatic preservative. It is provided in a multiple-dose container that allows for repeated withdrawals to dilute or dissolve injectable drugs. The pH of the solution is 5.7, within the range of 4.5 to 7.0.
Water for Injection, USP is chemically identified as H₂O. The semi-rigid vial is constructed from a specially formulated polyolefin, a copolymer of ethylene and propylene. The safety of this plastic has been validated through animal testing in accordance with USP biological standards for plastic containers. The container is designed without a vapor barrier, ensuring the maintenance of the proper labeled volume.
Uses and Indications
This parenteral preparation is indicated solely for the dilution or dissolution of drugs intended for intravenous, intramuscular, or subcutaneous injection, in accordance with the manufacturer's instructions for the specific drug to be administered.
Limitations of Use This preparation is not indicated for use in neonates.
Dosage and Administration
The volume of the preparation utilized for diluting or dissolving any drug for injection is contingent upon the vehicle concentration, the prescribed dose, and the route of administration as advised by the manufacturer.
Prior to administration, parenteral drug products must be visually inspected for particulate matter and discoloration, whenever the solution and container allow for such inspection. This step is crucial to ensure the safety and efficacy of the administered product.
Contraindications
Use of solutions containing benzyl alcohol is contraindicated in neonates due to the potential toxicity associated with this compound.
Additionally, parenteral preparations containing benzyl alcohol are not suitable for fluid replacement therapy.
These preparations should also be avoided in epidural or spinal anesthesia procedures to prevent adverse effects related to benzyl alcohol exposure.
Warnings and Precautions
Benzyl alcohol, a preservative present in Bacteriostatic Water for Injection, USP, has been linked to toxicity in neonates. Due to the lack of available data regarding the toxicity of other preservatives in this vulnerable age group, it is imperative that only preservative-free Sterile Water for Injection is utilized for the preparation or dilution of medications intended for neonates.
Healthcare professionals should also be aware that the intravenous administration of Bacteriostatic Water for Injection without an appropriate solute may lead to hemolysis. This risk underscores the necessity of ensuring that Bacteriostatic Water for Injection is used correctly and in conjunction with suitable solutes to prevent adverse effects.
Side Effects
Adverse reactions that may occur due to the use of this solution, added drugs, or the technique of reconstitution or administration include febrile response, local tenderness, abscess, tissue necrosis or infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, and extravasation.
Serious adverse reactions associated with the use of Bacteriostatic Water for Injection, USP, particularly in neonates, are of significant concern due to the presence of benzyl alcohol, a preservative linked to toxicity in this vulnerable population. Consequently, it is advised that only preservative-free Sterile Water for Injection be utilized for preparing or diluting medications intended for neonates.
Additionally, intravenous administration of Bacteriostatic Water for Injection without a solute may lead to hemolysis, underscoring the importance of proper administration techniques.
The safety and effectiveness of Bacteriostatic Water for Injection, USP have not been established in pediatric patients, and due to the potential for toxicity, solutions containing benzyl alcohol should not be used in neonates. Furthermore, parenteral preparations containing benzyl alcohol are contraindicated for fluid replacement and should not be employed in epidural or spinal anesthesia procedures.
Drug Interactions
Certain injectable medications may exhibit incompatibility when administered in the same vehicle or when combined with vehicles containing benzyl alcohol. It is advisable to consult with a pharmacist to ensure safe and effective administration of these drugs. Monitoring for potential adverse effects is recommended when using such combinations.
Packaging & NDC
The table below lists all NDC Code configurations of Bacteriostatic Water, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Details | ||||
|---|---|---|---|---|
| Injection, Solution | 1 mL/1 mL | ||
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Injection, Solution | 1 mL/1 mL | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
Pediatric Use
The safety and effectiveness of Bacteriostatic Water for Injection, USP, have not been established in pediatric patients. Caution is advised when considering its use in this population. Specifically, solutions containing benzyl alcohol should not be used in neonates due to the potential for toxicity.
Geriatric Use
There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments or safety concerns. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as they may have altered pharmacokinetics and pharmacodynamics. Close monitoring is recommended to ensure safety and efficacy in this population.
Pregnancy
Animal reproduction studies have not been conducted with Bacteriostatic Water for Injection. Therefore, it is not known whether Bacteriostatic Water for Injection containing additives can cause fetal harm when administered to a pregnant woman or affect reproductive capacity. Given the lack of data, Bacteriostatic Water for Injection, USP containing additives should be administered to pregnant patients only if clearly needed. Healthcare professionals should weigh the potential benefits against any unknown risks when considering the use of this product in pregnant women.
Lactation
Lactating mothers should be aware that solutions containing benzyl alcohol are contraindicated in neonates due to the potential toxicity associated with this compound. Therefore, lactating mothers should avoid using any medications that contain benzyl alcohol when breastfeeding.
When preparing or diluting medications for use in neonates, it is essential to utilize only preservative-free Sterile Water for Injection. This precaution helps ensure the safety of breastfed infants.
Renal Impairment
There is no specific information regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this population to ensure safety and efficacy.
Hepatic Impairment
Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.
Overdosage
In cases of overdosage, it is important to note that this parenteral preparation is intended solely for use as a diluent or solvent. The risk of fluid overload is generally low; however, caution should be exercised, particularly in very small infants, who may be more susceptible to such complications.
Should symptoms of overdosage arise, healthcare professionals are advised to re-evaluate the patient’s condition promptly. Appropriate corrective measures should be instituted based on the clinical assessment. Continuous monitoring and supportive care may be necessary to ensure patient safety and mitigate any potential adverse effects.
Nonclinical Toxicology
Animal reproduction studies have not been conducted with Bacteriostatic Water for Injection. It is not known whether Bacteriostatic Water for Injection containing additives can cause fetal harm when administered to a pregnant woman or affect reproductive capacity. Therefore, Bacteriostatic Water for Injection, USP containing additives should be given to a pregnant woman only if clearly needed.
Benzyl alcohol, a preservative in Bacteriostatic Water for Injection, USP, has been associated with toxicity in neonates. Data are unavailable on the toxicity of other preservatives in this age group.
Although adverse reactions to intravenous, intramuscular, or subcutaneous injection of 0.9% benzyl alcohol are not known to occur in humans, experimental studies of small volume parenteral preparations containing 0.9% benzyl alcohol in several species of animals have indicated that an estimated intravenous dose of up to 30 mL may be safely administered to an adult without toxic effects. However, administration of an estimated 9 mL to a 6 kg infant or neonate is potentially capable of producing blood pressure changes.
The safety of the plastic used in Bacteriostatic Water for Injection has been confirmed by tests in animals according to USP biological standards for plastic containers.
Postmarketing Experience
Benzyl alcohol, a preservative in Bacteriostatic Water for Injection, USP, has been associated with toxicity in neonates. Data regarding the toxicity of other preservatives in this age group are not available. For the preparation or dilution of medications intended for neonates, it is recommended to use only preservative-free Sterile Water for Injection.
Intravenous administration of Bacteriostatic Water for Injection without a solute may lead to hemolysis. Reactions that may occur due to this solution, the added drugs, or the technique of reconstitution or administration include febrile response, local tenderness, abscess, tissue necrosis or infection at the injection site, venous thrombosis or phlebitis extending from the injection site, and extravasation.
In the event of an adverse reaction, it is advised to discontinue the infusion, evaluate the patient, implement appropriate countermeasures, and, if feasible, retrieve and save the remainder of the unused vehicle for examination. Although adverse reactions to intravenous, intramuscular, or subcutaneous injection of 0.9% benzyl alcohol are not known to occur in humans, experimental studies in various animal species have suggested that an estimated intravenous dose of up to 30 mL may be safely administered to an adult without toxic effects. However, the administration of an estimated 9 mL to a 6 kg infant or neonate may potentially result in blood pressure changes.
Patient Counseling
Healthcare providers should advise patients that the medication is not intended for use in neonates. It is essential to consult the manufacturer's instructions regarding the choice of vehicle, appropriate dilution, and volume for dissolving the drugs to be injected, including the specified route and rate of injection.
Patients should be informed about the importance of inspecting reconstituted drugs for clarity and ensuring there is no unexpected precipitation or discoloration prior to administration. Additionally, it is crucial to use Bacteriostatic Water for Injection, USP containing additives in pregnant women only if it is clearly needed.
Healthcare providers must emphasize the necessity of employing aseptic techniques during single or multiple entries and withdrawals from all containers. When diluting or dissolving drugs, patients should be instructed to mix thoroughly and use the solution promptly. It is important to note that reconstituted solutions of drugs for injection should not be stored unless otherwise directed by the manufacturer of the solute.
Patients should be cautioned not to use the solution unless it is clear and the seal is intact. In the event of an adverse reaction, healthcare providers should instruct patients to discontinue the infusion immediately, evaluate their condition, institute appropriate countermeasures, and, if possible, retrieve and save the remainder of the unused vehicle for examination.
Storage and Handling
The product is supplied in accordance with the National Drug Code (NDC) specifications. It should be stored at a controlled room temperature of 20 to 25°C (68 to 77°F), as defined by the United States Pharmacopeia (USP) guidelines. Proper storage conditions are essential to maintain the integrity and efficacy of the product.
Additional Clinical Information
Patients may receive the medication via intravenous, intramuscular, or subcutaneous routes. Clinicians are advised to consult the manufacturer's instructions for guidance on the selection of the appropriate vehicle, as well as the correct dilution or volume for dissolving the drugs intended for injection, including details on the route and rate of administration.
FDA Insert (PDF)
This document is the official FDA-approved prescribing information for Bacteriostatic Water as submitted by Hospira, Inc.. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.